The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

In three months, the distribution of RSV vaccines will begin in the Americas, according to a PAHO announcement.

With cold and flu season around the corner, Doctors recommend receiving the RSV vaccine ahead of the holidays.

Health Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older, ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The bivalent RSV prefusion F vaccine (Abrysvo) demonstrated 90% vaccine effectiveness (VE) in high-risk adults against ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...

Researchers sought to determine if the RSV vaccine leads to better health outcomes among older adults with IBD.

A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% protection against severe illness and/or hospitalization. With U.S ...

Notably, quarterly sales of the company’s RSV vaccine, which became a blockbuster after debuting last year, fell by more than 70% year over year, in part due to narrower U.S. recommendations for ...